SCHEMBL7147398

SCHEMBL7147398

C=CCOCC#CCOCC=C

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10913349 0.86
SCHEMBL1662276 0.84
SCHEMBL3202977 0.80 CA1 (0.34) CA1CA2CA9ALDH1A1MEN1
SCHEMBL4130041 0.79
SCHEMBL7885944 0.78 TSHR (0.37) ALDH1A1MEN1POLBKMT2A
SCHEMBL3202967 0.78 MEN1 (0.32) CA1CA2MEN1POLBKMT2A
SCHEMBL2456839 0.77
SCHEMBL7868272 0.77
SCHEMBL588402 0.77
SCHEMBL7948676 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042854-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) 2025-02-06 US disclosed
EP-4433451-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF Ecole Nationale Supérieure de Chimie de Rennes (FR) 2024-09-25 EP disclosed
WO-2023088919-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) 2023-05-25 WO disclosed
US-8648003-B2 Catalysts for ring-closing metathesis AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-02-11 US disclosed
US-8648003-B2 Catalysts for ring-closing metathesis AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-02-11 US disclosed
US-8501656-B2 2013-08-06 US disclosed
US-8501656-B2 2013-08-06 US disclosed
US-20130131353-A1 CATALYSTS FOR RING-CLOSING METATHESIS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-05-23 US disclosed
US-20130131353-A1 CATALYSTS FOR RING-CLOSING METATHESIS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-05-23 US disclosed
US-20090170692-A1 CATALYSTS FOR RING-CLOSING METATHESIS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH 2009-07-02 US disclosed
US-4839325-A FLUORINATED, 2,4 PENTADIONE AND FATTY ACID METAL SALT; INCREASED POT LIFE MONSANTO COMPANY (US) 1989-06-13 US disclosed
US-4826923-A Allyloxy activated surface coatings MONSANTO COMPANY (US) 1989-05-02 US disclosed
US-4816535-A FREE RADICAL-POLYMERIZABLE COMPOUND, FUGITIVE ACID-STABILIZED METAL DRIER AND PEROXIDE INITIATOR MONSANTO COMPANY (US) 1989-03-28 US disclosed
US-4810757-A MODERATED METAL DRIER MONSANTO COMPANY (US) 1989-03-07 US disclosed
EP-0296141-A2 Allyloxy activated surface coatings Monsanto Company (US) 1988-12-21 EP disclosed
EP-0296140-A2 Allyloxy-activated surface coatings Monsanto Company (US) 1988-12-21 EP disclosed
US-4778864-A COATINGS WITH FREE RADICAL POLYMERIZABLE COMPOUNDS AND ALLYLOXY COMPOUNDS; LONG POT LIFE MONSANTO COMPANY (US) 1988-10-18 US disclosed
EP-0273025-A2 Stabilized metal drier MONSANTO COMPANY (US) 1988-06-29 EP disclosed
US-4670308-A FREE RADICAL POLYMERIZATION MONSANTO COMPANY (US) 1987-06-02 US disclosed
EP-0210158-A1 Surface coating process Monsanto Company (US) 1987-01-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042854-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF SQLE, SYMPK, FDFT1 CA1 3854/4885CA2 2715/4885CA9 3932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.